Seeing Is Believing

Currently out of the existing stock ratings of John Eade, 265 are a BUY (86.04%), 43 are a HOLD (13.96%).
Analyst John Eade, currently employed at ARGUS, carries an average stock price target met ratio of 80.28% that have a potential upside of 24.2% achieved within 406 days.
John Eade’s has documented 565 price targets and ratings displayed on 72 stocks. The coverage is on Industrials, Healthcare, Consumer Cyclical, Financial Services, Technology, Consumer Defensive, Basic Materials, Industrial Goods sectors.
Most recent stock forecast was given on FTV, Fortive Corp at 19-Aug-2026.
Analyst best performing recommendations are on MRNA (MODERNA).
The best stock recommendation documented was for MRNA (MODERNA) at 6/24/2021. The price target of $230 was fulfilled within 5 days with a profit of $9.86 (4.48%) receiving and performance score of 8.96.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 29-Dec-2025
$305
$90.8 (42.39%)
$295
Sell Since 24-Apr-2025
$300
$85.8 (40.06%)
$140
Buy Since 01-Feb-2024
$265
$50.8 (23.72%)
$275
Buy Since 15-Dec-2021
$290
$75.8 (35.39%)
$270
Hold Since 15-Mar-2023
$250
$32.75 (15.07%)
$235
Which stock is John Eade is most bullish on?
Which stock is John Eade is most reserved on?
What Year was the first public recommendation made by John Eade?